Christine Kilgore

Medication authorization letters, patient handouts, and patient triage are among top use cases of AI in DermGPT and are likely the top applications

Christine Kilgore March 11, 2026 The therapeutic landscape for polymyalgia rheumatica (PMR) has grown and will grow further, allowing

Christine Kilgore March 13, 2026 A study from the UK showing that early intensive therapy was superior to standard step-up therapy

Christine Kilgore April 03, 2026 Hadar Lev-Tov, MD, who directs the Miami HS Center at the University of Miami School of Medicine, is

With the IL-23 blockers, for the first time ever, we've also seen a disconnect between drug levels in the blood and the ability to stay in remission. With all the other

Christine Kilgore August 05, 2026 Knowledge of breast, nipple, and areolar (BNA) diseases is important for dermatologic care of all

Gender-affirming practices from hormones to chest binding and surgery introduce additional diagnostic considerations to an array of differentials for breast skin diseases.

Low-dose oral minoxidil ranks high as a first-line alopecia treatment option for transmasculine individuals and, especially in combination with spironolactone, for transfeminine patients.

In Friedman's toolbox, low-dose oral minoxidil (LDOM) ranks high as a first-line option for transmasculine individuals and, especially in combination with spironolactone (used off-label for female-pattern hair loss), for transfeminine patients.

January 1, 2005 | Family Practice News Author and Disclosure Information